Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Beximco Pharma (BXP) Share Price

Price 40.00p on 23-04-2025 at 18:25:12
Change 2.00p 5.26%
Buy 41.00p
Sell 39.00p
Buy / Sell BXP Shares
Last Trade: Sell 4,000.00 at 39.00p
Day's Volume: 64,999
Last Close: 40.00p
Open: 38.00p
ISIN: US0885792061
Day's Range 38.00p - 40.00p
52wk Range: 20.00p - 41.00p
Market Capitalisation: £178m
VWAP: 38.83761p
Shares in Issue: 446m

Beximco Pharma (BXP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 4,000 39.00p Ordinary
12:54:38 - 23-Apr-25
Sell* 2,900 39.26p Ordinary
12:52:50 - 23-Apr-25
Sell* 30,000 39.00p Ordinary
12:52:32 - 23-Apr-25
Sell* 5,000 39.00p Ordinary
12:51:32 - 23-Apr-25
Unknown* -5,000 37.00p Ordinary
Correction
12:51:32 - 23-Apr-25
Sell* 5,000 37.00p Ordinary
12:51:32 - 23-Apr-25
Buy* 22,599 38.50p Ordinary
11:14:10 - 23-Apr-25
Buy* 500 38.98p Ordinary
08:49:34 - 23-Apr-25
Buy* 4,000 39.00p Ordinary
11:43:34 - 16-Apr-25
Buy* 1,000 38.98p Ordinary
11:24:16 - 16-Apr-25
See more Beximco Pharma trades

Beximco Pharma (BXP) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd Apr 2025 (Wed) 38.00 40.00 38.00 40.00 64,999
22nd Apr 2025 (Tue) 38.00 38.00 38.00 38.00 0
21st Apr 2025 (Mon) 38.00 38.00 38.00 38.00 0
18th Apr 2025 (Fri) 38.00 38.00 38.00 38.00 0
17th Apr 2025 (Thu) 38.00 38.00 38.00 38.00 0
16th Apr 2025 (Wed) 38.00 38.00 38.00 38.00 6,099
15th Apr 2025 (Tue) 38.00 38.40 38.00 38.00 2,000
14th Apr 2025 (Mon) 38.00 38.00 38.00 38.00 0
11th Apr 2025 (Fri) 38.00 38.00 38.00 38.00 0
10th Apr 2025 (Thu) 38.00 38.00 38.00 38.00 37,341
9th Apr 2025 (Wed) 37.50 37.50 37.50 37.50 13,302
8th Apr 2025 (Tue) 37.50 37.50 37.50 37.50 9,132
7th Apr 2025 (Mon) 39.50 39.50 37.00 37.00 81,794
4th Apr 2025 (Fri) 40.00 40.00 40.00 40.00 185,136
3rd Apr 2025 (Thu) 40.00 40.00 40.00 40.00 10,823
2nd Apr 2025 (Wed) 38.70 40.00 38.70 40.00 162,364
1st Apr 2025 (Tue) 38.70 38.70 38.70 38.70 0
31st Mar 2025 (Mon) 38.50 38.60 38.60 38.60 10,827
28th Mar 2025 (Fri) 38.50 38.50 38.50 38.50 1
27th Mar 2025 (Thu) 38.50 38.50 38.50 38.50 74,000
26th Mar 2025 (Wed) 38.50 38.50 38.50 38.50 34,986
25th Mar 2025 (Tue) 38.00 38.50 38.00 38.50 7,675
24th Mar 2025 (Mon) 38.00 38.00 38.00 38.00 500
See more Beximco Pharma price history

Beximco Pharma (BXP) Regulatory News

Date Source Headline
21st Mar 2025 3:51 pm RNS Response to media reports and update on BSEC order
6th Mar 2025 7:00 am RNS Update on BSEC order
30th Jan 2025 2:59 pm RNS Payment of Cash Dividend
29th Jan 2025 7:01 am RNS Board Changes
29th Jan 2025 7:00 am RNS Half Year Results 2024-25
14th Jan 2025 11:24 am RNS Board of Directors
30th Dec 2024 7:00 am RNS Annual General Meeting Statement
19th Nov 2024 7:00 am RNS AGM Notification
14th Nov 2024 7:00 am RNS Financial Results for the First Quarter
12th Nov 2024 10:00 am RNS Restoration - Beximco Pharmaceuticals Limited
See more Beximco Pharma regulatory news

Beximco Pharma (BXP) Share News

IN BRIEF: Beximco denies "all media allegations of corruption"

21st Mar 2025 16:20

Beximco Pharmaceuticals PLC - Dhaka, Bangladesh-based producer of pharmaceutical ingredients - Releases statement, originally published on Wednesday in Bangladesh, denying allegations of corruption in the Covid-19 vaccine procurement process. Says these allegations circulated in the Bangladeshi media on Monday and Tuesday, following the launch of an anti-corruption commission investigation. Statement says Beximco "is deeply concerned and disappointed by the misleading and defamatory news [reports]", adding: "The company rejects these baseless allegations and protests the sensationalized and slanderous headlines, that not only tarnished corporate reputation as a globally known pharmaceutical manufacturer and exporter but also confused thousands of its valued shareholders, especially many foreign investors who currently hold more than 32% of company's shares." Claims that "several" media outlets "clearly attempted to malign Beximco Pharma". Furthermore, Beximco "firmly asserts that it conducted all transactions with necessary approvals from the regulatory authorities". "Says it reserves the right to take appropriate legal action against such defamatory reporting". Read More

Beximco Pharma petitions board appointments amid fraud allegations

14th Jan 2025 14:32

(Alliance News) - Beximco Pharmaceuticals Ltd on Tuesday said it had issued a petition against nine appointments to its board by the Bangladesh Securities and Exchange Commission. Read More

Beximco Pharmaceuticals says full court hearing set for October 28

2nd Oct 2024 12:12

(Alliance News) - Beximco Pharmaceuticals Ltd on Wednesday said the Bangladesh court has referred the company's appeal in its recent fraud case to a full-court hearing, which will take place on October 28. Read More

IN BRIEF: Beximco Pharma vice-chair arrested for ties to ousted PM

15th Aug 2024 11:28

Beximco Pharmaceuticals - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Confirms that Vice-Chair Salman Rahman was arrested by Dhaka police on Tuesday and will be held for 10 days while an investigation into alleged offences is carried out. Rahman was a private industry and investment advisor to deposed Bangladesh prime minister Sheikh Hasina, who fled the country earlier this month amid accusations of human rights abuses. Read More

IN BRIEF: Beximco Pharma says Bangladesh unrest reduced distribution

13th Aug 2024 13:44

Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Distribution of products was reduced in response to the recent civil unrest in Bangladesh, in the interest of employee safety, but it is now returning to normal levels. "The interim government of Bangladesh has indicated that it intends to address any ongoing unrest as a priority, and we expect to be able to resume normal distribution in the coming days," Beximco says. No significant damage was done to its manufacturing and distribution facilities, and the company says it doesn't expect the disruption to have a "material impact" on annual results. Read More

See more Beximco Pharma news
FTSE 100 Latest
Value8,403.18
Change74.58

Login to your account

Forgot Password?

Not Registered